Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review

RATIONALE: Management of anxiety, delirium, and agitation cannot be neglected in coronavirus disease (COVID-19). Antipsychotics are usually used for the pharmacological management of delirium, and confusion and behavioral disturbances. The concurrent use of treatments for COVID-19 and antipsychotics...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Psychopharmacology (Berl)
Autori principali: Plasencia-García, Beatriz Oda, Rodríguez-Menéndez, Gonzalo, Rico-Rangel, María Isabel, Rubio-García, Ana, Torelló-Iserte, Jaime, Crespo-Facorro, Benedicto
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2021
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7788177/
https://ncbi.nlm.nih.gov/pubmed/33410987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-020-05716-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi